HG-67PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPGDiana Carvalho, Chris Jones, Nagore G. Olaciregui et al.|Neuro-Oncology|2016Cited by 1